ResearcherUniversity of OuluNo recent work listed
Peeter Karihtala
Matched on ORCID iD 0000-0003-3490-3702; OpenAlex author ID A5042480143. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 2 papers
Papers 7
- Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001195↗
- Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival. Co-author DOI 10.1159/000494274↗
- Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma. Last author DOI 10.1016/j.prp.2018.04.016↗
- KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinoma. Last author DOI 10.21873/anticanres.12474↗
- Loss of Peroxiredoxin Expression Is Associated with an Aggressive Phenotype in Pancreatic Adenocarcinoma. Last author PMID 26722077↗
- Strong claudin 5 expression is a poor prognostic sign in pancreatic adenocarcinoma. Last author DOI 10.1007/s13277-013-1503-7↗
- Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma. Last author DOI 10.1016/j.prp.2013.10.001↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kirsi‐Maria Haapasaari · 7 shared papers, 2014–2019 · strength 0.61
- Paper KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinom… DOI 10.21873/anticanres.12474↗
- Paper Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiati… DOI 10.1159/000494274↗
- Paper Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarc… DOI 10.1016/j.prp.2018.04.016↗
- Ylermi Soini · 6 shared papers, 2014–2019 · strength 0.52
- Paper KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinom… DOI 10.21873/anticanres.12474↗
- Paper Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiati… DOI 10.1159/000494274↗
- Paper Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarc… DOI 10.1016/j.prp.2018.04.016↗
- Joel Isohookana · 4 shared papers, 2016–2019 · strength 0.40
- Paper KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinom… DOI 10.21873/anticanres.12474↗
- Paper Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarc… DOI 10.1016/j.prp.2018.04.016↗
- Paper Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001195↗
- Joni Leppänen · 2 shared papers, 2018–2019 · strength 0.19
- Joonas H. Kauppila · 1 shared paper, 2019 · strength 0.09
- Heikki I. Huhta · 1 shared paper, 2019 · strength 0.09
- Tuomo J. Karttunen · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.